GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Egetis Therapeutics AB (LTS:0ABW) » Definitions » Cash Receipts from Fees and Commissions

Egetis Therapeutics AB (LTS:0ABW) Cash Receipts from Fees and Commissions


View and export this data going back to 2023. Start your Free Trial

What is Egetis Therapeutics AB Cash Receipts from Fees and Commissions?

Cash Receipts from Fees and Commissions only applicable to companies reporting Cash Flow from Operations in direct method.


Egetis Therapeutics AB Business Description

Industry
Traded in Other Exchanges
Address
Grev Turegatan 11 C, Stockholm, SWE, 114 46
Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.